Dry eye, which affects around 30% of the population, is a pathology that is on the rise in today’s society and is influenced by different habits (such as diet or the use of screens) and environmental factors, including: pollution. Air pollution is a growing problem with a global impact that, according to the WHO, affects …
Most common risk factor Glaucoma encompasses a group of pathologies that cause progressive damage to the optic nerve, which is responsible for transmitting the images that reach the retina so that the brain can interpret them. As the disease progresses, this nerve loses its fibers and, as a result, the patient’s visual field decreases, which …
Most common risk factor The main risk factor that can trigger glaucoma is ocular hipertension. This condition usually occurs because, the aqueous humor (fluid that bathes the inner eye) does not drain properly and builds up, putting excessive pressure on the optic nerve and causing a “stress” that it cannot withstand. Other risk factors However, …
Glaucoma is one of the most common causes of blindness and comprises a group of diseases that cause progressive and irreversible damage to the optic nerve. This structure is key to vision since, through it, the images captured by the retina (converted into nerve impulses) are transmitted to the brain so that it can interpret them and …
Generally, dry eye is caused by a tear deficit (low production or excessive evaporation) or because it is of poor quality due to problems such as meibomian gland dysfunction (lack or alteration of the lipids that make up the tear) or blepharitis (inflammation of the eyelid). In addition, it is usually associated with different degrees …
Dry eye is a multifactorial, complex and chronic disease that affects the ocular surface and causes discomfort, visual problems and, in some cases, lesions in the cornea and conjunctiva. Therefore, and despite the fact that its name can be misleading, it consists of much more than simply “not having a tear”. It is a chronic …
The biggest international pharma industry event is back! Join us at CPHI Frankfurt 2022! We’re excited to announce that we’ll be exhibiting this year at CPHI Frankfurt 2022 in Frankfurt, Germany on 1-3 November 2022. Start your CPHI Journey online from 28 September during Connect to Frankfurt! Put yourself at the heart of Pharma innovation by …
The most important B2B event in the Americas! Lansier will participate in Be Pharma 2022 – Mexico, from October 10 to 12. BePharma is a business plataform where managers and representatives of companies from all healthcare divisions of different countries meet to create new business opportunities in the global pharmaceutical market. Enter here to learn more …
Lansier LaboratoriesMaking the world see better
